Barinthus Biotherapeutics (BRNS) Debt Ratio (2021)
Barinthus Biotherapeutics' (BRNS) quarterly Debt Ratio came in at 0.0 in Q4 2021.
Barinthus Biotherapeutics (BRNS) Debt Ratio (2021) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 1 years of Debt Ratio data on file, last reported at 0.0 in Q4 2021.
- Quarterly Debt Ratio changed N/A year-over-year to 0.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was 0.0 (changed N/A YoY) and the FY2021 annual result came in at 0.0, changed N/A from the prior year.
- Debt Ratio steadied at 0.0 in Q4 2021.
- In the past five years, Debt Ratio ranged from a high of 0.0 in Q4 2021 to a low of 0.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - | 0.47 |
| 10 | Barinthus Biotherapeutics | 25.29 Mn | 25.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 0.00 |